⌘K

Login Start Free

Home/Filings/4/0001104659-21-088251

4//SEC Filing

Maynard Ryan D 4

Accession 0001104659-21-088251

CIK 0001425205other

View on SEC.gov Company Profile

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 4:18 PM ET

Size

5.7 KB

Accession

0001104659-21-088251

Insider Transaction Report

Form 4

Period: 2021-06-29

IOVANCE BIOTHERAPEUTICS, INC.IOVA

Director

Transactions

Award
Stock Option (right to buy)
2021-06-29+35,000→ 35,000 total
Exercise: $26.33Exp: 2031-06-29→ Common Stock (35,000 underlying)

Footnotes (1)

[F1]These options are exercisable in four equal quarterly installments of 8,750 each following the date of grant, such that the options will be fully vested and exercisable on June 29, 2022.

Documents

1 file

4
tm2121236-3_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

IOVANCE BIOTHERAPEUTICS, INC.

CIK 0001425205

Entity typeother

Related Parties

1

filerCIK 0001363984

Filing Metadata

Form type: 4
Filed: Jun 30, 8:00 PM ET
Accepted: Jul 1, 4:18 PM ET
Size: 5.7 KB

View on SEC.gov